ERBB2 is a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases, and its IgG autoantibody has been extensively assessed as a potential diagnostic biomarker for gastric cancer (32) and breast cancer (33). Here, NTRK1 is linked to breast carcinoma.